Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Deletion mapping of 6q21-26 and frequency of 1p36 deletion in childhood endodermal sinus tumors by microsatellite analysis

Abstract

The most common malignant germ cell tumor of early childhood is the endodermal sinus tumor (CEST), also known as yolk sac tumor. Previous cytogenetic studies of CEST have demonstrated recurrent deletion of distal regions of chromosomes 1p and 6q. Studies utilizing comparative genomic hybridization have likewise demonstrated loss of distal 6q, however these studies show discrepant data concerning chromosome 1 abnormalities. This study analyses 18 CESTs for loss of heterozygosity (LOH) of distal chromosome 6q utilizing 17 microsatellite markers and 13 tumors were analysed for LOH of distal 1p using two microsatellite markers. LOH of 6q was found in 13/18 tumors (72 %). This data confirms that loss of genetic material on 6q is one of the most common abnormalities in CESTs and narrows the region of loss, enabling candidate tumor suppressor genes to be identified and analysed. In addition, LOH of 1p36 was identified in five of 11 informative tumors, clarifying prior conflicting data and confirming that 1p deletion is a common event in CESTs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Barghorn A, Speel EJ, Farspour B, Saremaslani P, Schmid S, Perren A, Roth J, Heitz PU, Komminoth P . 2001 Am. J. Pathol. 158: 1903–1911

  • Brodeur GM, Nakagawara A . 1992 Am. J. Pediatr. Hematol. Oncol. 14: 111–116

  • Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Idenburg VJS, Dam A, te Meerman G, Koops HS . 1989 Cancer Res. 49: 5696–5701

  • Cooke IE, Shelling AN, LeMeuth VG, Charnock ML, Ganesan TS . 1996 Genes, Chromosomes and Cancer 15: 223–233

  • Cooney KA, Wetzel JC, Consolino CM, Wojno KJ . 1996 Cancer Res. 56: 4150–4153

  • De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL . 1995a Nature Genetics 11: 447–449

  • De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL . 1995b Oncogene 10: 1725–1729

  • du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T . 1995 Cytometry 19: 27–41

  • Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM . 1989 Proc. Natl. Acad. Sci. 86: 3753–3757

  • Fujii H, Zhou W, Gabrielson E . 1996 Genes Chromosomes Cancer 16: 35–39

  • Gibas Z, Prout Jr GR, Sandberg AA . 1984 J. Urol. 131: 762–763

  • Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL . 1996 Oncogene 12: 2003–2009

  • Mathew S, Murty VVVS, Bosl GJ, Chaganti RSK . 1994 Cancer Research 54: 6265–6269

  • Oosterhuis JW, Castedo SMMJ, de Jong B, Seruca R, Buist J, Koops HS, Leeuw JB . 1988 Cancer Genet. Cytogenet. 36: 7–11

  • Perlman EJ, Cushing B, Hawkins E, Griffin CA . 1994 Ped. Pathol. 14: 695–708

  • Perlman EJ, Hu J, Ho D, Cushing B, Lauer S, Castleberry RP . 2000 J. Ped. Hematol. Onc. 22: 100–105

  • Perlman EJ, Valentine MB, Griffin CA, Look AT . 1996 Genes Chromosomes and Cancer 16: 15–20

  • Riopel M, Spellerberg A, Griffin CA, Perlman EJ . 1998 Cancer Res. 58: 3105–3110

  • Rodriguez C, Causse A, Ursule E, Theillet C . 2000 Genes Chromosomes Cancer 27: 76–84

  • Saito S, Saito H, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y . 1992 Cancer Res. 52: 5815–5817

  • Srikantan V, Sesterhenn IA, Davis L, Hankins GR, Avallone FA, Livezey JR, Connelly R, Mostofi FK, McLeod DG, Moul JW, Chandrasekharappa SC, Srivastava S . 1999 Int. J. Cancer 84: 331–335

  • Stock C, Ambros IM, Lion T, Haas OA, Zoubek A, Gadner H, Ambros PF . 1994 Cancer 11: 40–50

  • Theile M, Seitz S, Arnold W, Jandrig B, Frege R, Schlag PM, Haensch W, Guski H, Winzer KJ, Barrett JC, Scherneck S . 1996 Oncogene 13: 677–685

  • Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y, Emi M . 2000 Jpn. J. Cancer Res. 91: 293–300

Download references

Acknowledgements

This study was supported by the American Cancer Society RPG-97-113-01-CCE (EP) and the Dr Mildred Scheel grant from the German Cancer Aid (D Schneider), NIH UIOCA 28476 (EP), and NIH UIOCA 20549 (S Lauer). We also gratefully acknowledge the support of the Children's Cancer Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth J Perlman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, J., Schuster, A., Fritsch, M. et al. Deletion mapping of 6q21-26 and frequency of 1p36 deletion in childhood endodermal sinus tumors by microsatellite analysis. Oncogene 20, 8042–8044 (2001). https://doi.org/10.1038/sj.onc.1204961

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204961

Keywords

This article is cited by

Search

Quick links